These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 27154254)
1. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. Khan AM; Ahmad FJ; Panda AK; Talegaonkar S Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254 [TBL] [Abstract][Full Text] [Related]
2. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
3. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112 [TBL] [Abstract][Full Text] [Related]
4. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles produced by electrohydrodynamic atomisation for the passive delivery of imatinib. Tsilova SL; Schreiber BE; Lever R; Parhizkar M Eur J Pharm Biopharm; 2024 Sep; 202():114412. PubMed ID: 39013491 [TBL] [Abstract][Full Text] [Related]
7. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles. Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381 [TBL] [Abstract][Full Text] [Related]
9. Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond. Günday Türeli N; Türeli AE; Schneider M Int J Pharm; 2016 Sep; 511(2):994-1001. PubMed ID: 27520732 [TBL] [Abstract][Full Text] [Related]
10. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
11. In situ gel-forming AP-57 peptide delivery system for cutaneous wound healing. Li X; Fan R; Tong A; Yang M; Deng J; Zhou L; Zhang X; Guo G Int J Pharm; 2015 Nov; 495(1):560-571. PubMed ID: 26363112 [TBL] [Abstract][Full Text] [Related]
12. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy. Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580 [TBL] [Abstract][Full Text] [Related]
13. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Cai H; Liang Z; Huang W; Wen L; Chen G Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide. Bahari Javan N; Montazeri H; Rezaie Shirmard L; Jafary Omid N; Barbari GR; Amini M; Ghahremani MH; Rafiee-Tehrani M; Abedin Dorkoosh F Eur J Pharm Sci; 2017 Apr; 101():167-181. PubMed ID: 28193537 [TBL] [Abstract][Full Text] [Related]
16. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
18. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. Girotra P; Singh SK; Kumar G Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690 [TBL] [Abstract][Full Text] [Related]
19. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach. Günday Türeli N; Türeli AE; Schneider M Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035 [TBL] [Abstract][Full Text] [Related]
20. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies. Patil GB; Surana SJ J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]